Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

Thomas P. Miller, Steve Dahlberg, J. Robert Cassady et al. · New England Journal of Medicine · 1998 · 1K citations · Full text

Medicine, Oncology, Chemotherapy +11

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

Wing-Yan Au, Dennis D. Weisenburger, Tanin Intragumtornchai et al. · Blood · 2008 · 741 citations

Medicine, Oncology, Otolaryngology +12

Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas

Elaine S. Jaffe, John K.C. Chan, Ih‐Jen Su et al. · The American Journal of Surgical Pathology · 1996 · 733 citations

Medicine, Oncology, Pathology +17

Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study

Jeeyun Lee, Cheolwon Suh, Young Hyeh Ko et al. · Journal of Clinical Oncology · 2005 · 614 citations · Full text

Medicine, Oncology, Cancer Immunology +12

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim et al. · Journal of Clinical Oncology · 2011 · 602 citations

Pharmacy, Oncology, Pharmacotherapy +13